CLOV Clover Health Investments, Corp HOSPITAL & MEDICAL SERVICE PLANS

Clover Health Investments (CLOV) Stock: Buy, Sell, or Hold?

$4.93
+0.10 (+2.07%) ▲
5d: +14.92% 30d: +3.14% 90d: +8.59%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (26%)
Quality Score
39/100
Position
EXTENDED
30-Day Fair Range
$4.47 – $4.80
Position: EXTENDED
Forward P/E & Valuation
27.4x CHEAP
vs 34.9x historical avg
Wall Street Target
$5.60
+13.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.19 / $5.28
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CLOV shows conflicting indicators. Wait for confirmation before entering.
Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Nov 4, 2026 at $4.62 · last confirmed Nov 10, 2026

Strength: 6.2/10

Get Alerted When CLOV Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: CLOV is currently trading at $4.93, which is considered extended relative to its 30-day fair value range of $4.47 to $4.80. From a valuation perspective, the stock is trading at a discount (Forward PE: 27.4) compared to its historical average (34.9). Remarkably, the market is currently pricing in an annual earnings decline of 7.7% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, CLOV is in a downtrend. Immediate support is located at $4.19, while resistance sits at $5.28.

Market Sentiment: CLOV scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.60 (+13.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $4.47 - $4.80
Company Quality Score 39/100 (SELL)
Volume Confirmation HIGH
Confidence Score 26.2%

Trading Range & Key Levels

30-Day Trading Range $4.47 - $4.80
Current vs Trading Range EXTENDED
Support Level $4.19
Resistance Level $5.28
Current Trend Downtrend
Technical data as of Nov 10, 2026

Protect Your Profits

Holding CLOV? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BEARISH: Price extended above range
  • BEARISH: Weak technical setup (33/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($5.60)
  • WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 27.39
Wall Street Target $5.60 (+13.6%)
Revenue Growth (YoY) 53.1%
Profit Margin 0.4%
Valuation Discount vs History -7.7% cheaper
PE vs Historical 27.4 vs 34.9 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -7.7% (market-implied from PE analysis)
1-Year Target $4.55 (-8%)
2-Year Target $4.20 (-15%)
3-Year Target $3.88 (-21%)
3-Yr Target (if PE normalizes) (PE: 27→35) $4.94 (+0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 27.4, Growth: 28.6%) $10.48 (+113%)
Base: (SPY PE: 19.9, Growth: 28.6%) $7.60 (+54%)
Bear: (PE: 16.9, Growth: 28.6%) $6.46 (+31%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (27x PE) as earnings recover.
Forward PE: 37.74 | Forward EPS (Implied): $0.13
Bull Case $5.95 (+21%)
Analyst growth 15.0%, PE expands to 39.6
Base Case $4.93 (0%)
Market implied 0.0%, PE stable at 37.7
Bear Case $3.77 (-24%)
Severe decline -15.0%, PE contracts to 34.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 27.4 to 34.9
Stabilization Target: $6.28 (+27.4%)
PE Expansion Potential: +27.4%
Share CLOV Analysis

Share this live CLOV analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

Reddit StockTwits X / Twitter
bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (CLOV)

Bullish 10 Retail Mentions
Reddit / WSB Comments
2
Bearish
StockTwits Volume
8 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary: The latest article discusses three financially strong penny stocks, one of which is $CLOV, providing exposure to lower risk early-stage businesses with cleaner financial footing.
Key Retail Themes: Company's financial strength Brokerage platform exposure
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 5:13 AM ET
Data refreshes hourly during market hours. Next update: 6:13 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
See Full Scanner Results »
Technical Signals Check

Is CLOV showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CLOV.

Create Free Account

Already have an account? Log In

Top Rated Healthcare Plans Stocks

Top-rated stocks in Healthcare Plans by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CVS
CVS Health Corp 		STRONG BUY
27 analysts 		$115 50 HOLD
UNH
UnitedHealth Group Incor… 		STRONG BUY
26 analysts 		$477 53 HOLD
HUM
Humana Inc 		BUY
26 analysts 		$465 64 BUY
CI
The Cigna Group 		STRONG BUY
24 analysts 		$342 51 HOLD
ELV
Elevance Health Inc 		BUY
22 analysts 		$482 54 HOLD
CVS CVS Health Corp
50 HOLD
UNH UnitedHealth Grou…
53 HOLD
HUM Humana Inc
64 BUY
CI The Cigna Group
51 HOLD
ELV Elevance Health I…
54 HOLD

Advanced CLOV Option Strategies

Professional options setups generated by AI based on today's CLOV price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive CLOV Research Pages
CLOV Technical Chart CLOV Price Prediction CLOV Intrinsic Value DCF CLOV Earnings Date CLOV Investment Advisor CLOV Fair Price Analyzer CLOV Options Chain CLOV Options Advisor CLOV Options Analysis CLOV Competitors
Part B: Tradestie Flagship Market Scanners
Today's Best Signals (CLOV) Sector Rotation Monitor AI Supply Chain Money Flow Gamma Squeeze (GEX) Scanner Undervalued Stocks Scanner Insider Cluster Buying Reddit & WSB Sentiment Tracker Backtested Stock Scanner
Compare CLOV with Peers
CLOV vs FUBO
Which one to buy?
CLOV vs SNDL
Which one to buy?
CLOV vs WKHS
Which one to buy?
CLOV vs BB
Which one to buy?
CLOV vs OCGN
Which one to buy?
ROOT vs CLOV
CLOV vs WKHS
CRSR vs CLOV
CLOV vs MOH
CLOV vs FUBO
CLOV vs CNC
CLOV vs ALHC
Winner: CLOV
CLOV vs OSCR
CLOV vs PGNY
CLOV vs BB
Create New Comparison View All Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals